Newsletter | September 16, 2026

09.16.26 -- Novel Approach To Cancer Explores Severing Its Genetic Supply Line

SPONSOR

 

Expanding the therapeutic toolbox

What becomes possible when multiple genetic payloads can be delivered together? Explore how advances in lipid nanoparticles and multiplexing may help enable increasingly sophisticated therapeutic approaches, from gene editing to cancer immunotherapies.

FOCUS ON TRANSLATIONAL RESEARCH

Novel Approach To Cancer Explores Severing Its Genetic Supply Line

Gene ablation represents an important and novel approach to treating cancer. One company is focusing on disabling the NRF2 gene to starve cancer cells.

 

 

Tips And Tricks Addressing PCR Pain Points To Improve Precision

PCR processes are essential yet frequently derailed by small errors. Master strategic adjustments to eliminate technical pitfalls and safeguard your analytical data.

 

Defining The Necessary Steps In Antibody Development

Delve into antibody development and production, the processes and steps involved, and the screening and selection of antibody candidates.

 

mRNA LNPs Drive Safe, Effective Repeat Dosing In Disease Models

Repeat dosing may be essential for long-term mRNA applications. Explore safety, immune-response, and efficacy findings from multiple LNP administrations, including a nine-dose evaluation over six months.

 

Multicolor Flow Cytometry Panel Design

Watch a series of videos on multicolor flow cytometry panel design to gain a comprehensive understanding of the fundamentals of panel design as well as various strategies to streamline panel design.

 

How Organ-Chips Are Transforming Women's Reproductive Health Research

Traditional models often fall short in women’s health research. Learn how human-relevant Organ-Chip systems are providing new ways to study vaginal, cervical, and uterine biology.

 

Patient-Derived Organoids For Cell Therapy Development

Patient-derived organoids offer a more accurate way to test cell therapies by preserving the complex tumor environments that determine whether these treatments will actually work.

TRANSLATIONAL RESEARCH SOLUTIONS

Preclinical Genome Editing Risk Assessment Services - MaxCyte, Inc.

Increase Transgene Expression By Up To 7-Fold With This AAV System - Asimov

Connect With Cell & Gene: